Clorox Co. (NYSE:CLX) shares were down 1.2% during trading on Tuesday . The stock traded as low as $135.60 and last traded at $136.00, with a volume of 443,329 shares changing hands. The stock had previously closed at $137.71.

Several research analysts have commented on CLX shares. JPMorgan Chase & Co. reissued a “sell” rating and issued a $120.00 price target on shares of Clorox in a report on Monday, May 2nd. Barclays PLC raised their price target on shares of Clorox from $112.00 to $120.00 and gave the company an “underweight” rating in a report on Monday, March 21st. Zacks Investment Research downgraded shares of Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, July 5th. Atlantic Securities started coverage on shares of Clorox in a report on Tuesday, June 14th. They issued a “neutral” rating and a $138.00 price target for the company. Finally, Goldman Sachs Group Inc. raised their price target on shares of Clorox from $125.00 to $126.00 and gave the company a “neutral” rating in a report on Tuesday, May 3rd. Three investment analysts have rated the stock with a sell rating and seven have assigned a hold rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $124.10.

The firm has a market cap of $17.82 billion and a P/E ratio of 26.92. The company has a 50-day moving average price of $133.44 and a 200 day moving average price of $128.95.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, May 3rd. The company reported $1.21 EPS for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.10. The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the prior year, the company posted $1.08 earnings per share. The firm’s quarterly revenue was up 1.8% on a year-over-year basis. On average, equities analysts forecast that Clorox Co. will post $4.95 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 12th. Shareholders of record on Wednesday, July 27th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, July 25th. This is an increase from Clorox’s previous quarterly dividend of $0.77. This represents a $3.20 dividend on an annualized basis and a yield of 2.33%.

In other news, COO Nikolaos A. Vlahos sold 2,151 shares of the stock in a transaction on Tuesday, May 10th. The shares were sold at an average price of $132.25, for a total value of $284,469.75. Following the completion of the sale, the chief operating officer now directly owns 13,883 shares of the company’s stock, valued at $1,836,026.75. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Other hedge funds have recently made changes to their positions in the company. BOKF NA boosted its stake in shares of Clorox by 36.3% in the fourth quarter. BOKF NA now owns 38,885 shares of the company’s stock worth $4,932,000 after buying an additional 10,366 shares during the period. Pinnacle Associates Ltd. raised its position in shares of Clorox by 16.8% in the fourth quarter. Pinnacle Associates Ltd. now owns 29,085 shares of the company’s stock worth $3,689,000 after buying an additional 4,177 shares in the last quarter. Private Advisor Group LLC raised its position in shares of Clorox by 55.1% in the fourth quarter. Private Advisor Group LLC now owns 25,681 shares of the company’s stock worth $3,257,000 after buying an additional 9,119 shares in the last quarter. GAM Holding AG raised its position in shares of Clorox by 17.6% in the fourth quarter. GAM Holding AG now owns 18,036 shares of the company’s stock worth $2,288,000 after buying an additional 2,693 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Clorox by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 12,819,276 shares of the company’s stock worth $1,625,869,000 after buying an additional 273,177 shares in the last quarter.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.